Summary: This eBook includes an overview of outsourcing trends in the oral solid dose market. Featured articles describe the robust market resulting from the demand for specialized dosage forms such as controlled release, pediatric and geriatric delivery vehicles.
Summary: OneXpress® is a single integrated solution that provides the fastest pathway from clinical to commercial manufacturing.
Summary: Learn more about how the transition from early to late phase of a small molecule program plays a pivotal role in a program’s ultimate success.
Summary: Catalent CEO Johh Chiminski discusses how the pandemic has made us question how the future of pharma manufacturing will be altered post Covid-19.
Summary: In this webinar, Catalent experts will explain how the phase appropriate expertise and technologies of the OneXpress® Solution can help streamline development and manufacturing, speed up your program timelines and reduce risks to transform your science into a successful treatment.
Summary: Phase-appropriate CMC-related activities can facilitate the transition from early development through commercialization.
